Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75.53 USD | -1.69% | -1.74% | +5.71% |
12-10 | BNP Paribas Exane Trims Hologic Price Target to $95 From $96, Maintains Outperform Rating | MT |
12-09 | Hologic, Inc. Elects Martin Madaus to Board of Directors | CI |
Business description: Hologic, Inc.
- molecular diagnostics (46.7%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin;
- breast health (35.5%): digital mammography and breast biopsy solutions and systems;
- gynecological surgery (15%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures;
- bone health (2.8%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment.
Net sales break down by source of revenue between sales of products (81.4%) and services (18.6%).
Net sales are distributed geographically as follows: the United States (75.9%), Europe (12.9%), Asia/Pacific (6.3%) and other (4.9%).
Number of employees: 6,990
Sales by Activity: Hologic, Inc.
Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Diagnostics | 1.21B | 2.1B | 3.7B | 3.02B | 1.88B |
Breast Health | 1.31B | 1.15B | 1.35B | 1.23B | 1.43B |
GYN Surgical | 437M | 376M | 488M | 523M | 604M |
Skeletal Health | 94.8M | 81M | 96.9M | 93.6M | 113M |
Medical Aesthetics | 316M | 65.3M | - | - | - |
Geographical breakdown of sales: Hologic, Inc.
Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
United States | 2.54B | 2.86B | 3.9B | 3.47B | 3.06B |
Europe | 396M | 570M | 1.2B | 888M | 520M |
Asia-Pacific | 286M | 227M | 365M | 360M | 256M |
All Others | 149M | 117M | 163M | 147M | 196M |
Managers: Hologic, Inc.
Director | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 06/12/2013 | |
Karleen Oberton
DFI | Director of Finance/CFO | 54 | 31/07/2018 |
Essex Mitchell
COO | Chief Operating Officer | 44 | 31/12/2023 |
Paul Malenchini
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2021 |
Ryan Simon
IRC | Investor Relations Contact | - | 31/12/2021 |
Members of the board: Hologic, Inc.
Manager | Title | Age | Since |
---|---|---|---|
Sally Crawford
BRD | Director/Board Member | 70 | 21/10/2007 |
Director/Board Member | 53 | 31/10/2011 | |
Scott Garrett
BRD | Director/Board Member | 73 | 05/05/2013 |
Chairman | 60 | 15/06/2015 | |
Director/Board Member | 69 | 14/05/2017 | |
Director/Board Member | 63 | 30/11/2016 | |
Ludwig Hantson
BRD | Director/Board Member | 61 | 20/11/2018 |
Stacey Stewart
BRD | Director/Board Member | 59 | 01/01/2023 |
Nanaz Mohtashami
BRD | Director/Board Member | 46 | 19/09/2023 |
Martin Madaus
BRD | Director/Board Member | 64 | 05/12/2024 |
Company details: Hologic, Inc.
Group companies: Hologic, Inc.
Name | Category and Sector |
---|---|
Diagenode SA
Diagenode SA Medical SpecialtiesHealth Technology Diagenode SA provides solutions for epigenetics research, biological sample preparation, and diagnostics assays. It offers Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company was founded in 2003 and is headquartered in Seraing, Belgium. |
Medical Specialties
|
Hologic HUB Ltd.
Hologic HUB Ltd. Medical DistributorsDistribution Services Part of Hologic, Inc., Hologic HUB Ltd. is a healthcare product distributor. The company is based in Manchester, UK. Founded in 2015, Hologic HUB distributes healthcare products. |
Medical Distributors
|
Other Advanced Medical Equipment & Technology
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-1.69% | -1.74% | +9.97% | +1.04% | 17.44B | ||
-0.28% | +1.04% | +7.95% | -16.83% | 205B | ||
+1.02% | -1.15% | +72.34% | +57.58% | 192B | ||
+0.45% | -0.36% | +6.35% | -25.86% | 169B | ||
+0.40% | -0.31% | +63.88% | +119.97% | 133B | ||
+1.08% | +4.52% | +3.48% | -19.47% | 62.94B | ||
-0.26% | +1.06% | -11.93% | -29.22% | 43.85B | ||
+0.57% | -0.53% | +4.98% | -39.42% | 43.29B | ||
-0.52% | +0.71% | +9.48% | -9.64% | 40.48B | ||
+0.47% | -0.31% | +16.34% | - | 37.63B | ||
Average | +0.12% | +0.24% | +18.28% | +4.24% | 94.44B | |
Weighted average by Cap. | +0.33% | -0.14% | +27.68% | +16.07% |
Sector
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HOLX Stock
- Company Hologic, Inc.
MarketScreener is also available in this country: United States.
Switch edition